Your browser doesn't support javascript.
loading
Permanent acceptance of mouse cardiac allografts with CD40 siRNA to induce regulatory myeloid cells by use of a novel polysaccharide siRNA delivery system.
Zhang, Q; Ichimaru, N; Higuchi, S; Cai, S; Hou, J; Fujino, M; Nonomura, N; Kobayashi, M; Ando, H; Uno, A; Sakurai, K; Mochizuki, S; Adachi, Y; Ohno, N; Zou, H; Xu, J; Li, X-K; Takahara, S.
Affiliation
  • Zhang Q; 1] Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan [2] Huashan Hospital, Fudan University, Shanghai, China.
  • Ichimaru N; Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Higuchi S; NapaJen Pharma, Inc., Tokyo, Japan.
  • Cai S; 1] Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan [2] Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hou J; 1] Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan [2] Huashan Hospital, Fudan University, Shanghai, China.
  • Fujino M; 1] Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan [2] AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Nonomura N; Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kobayashi M; NapaJen Pharma, Inc., Tokyo, Japan.
  • Ando H; NapaJen Pharma, Inc., Tokyo, Japan.
  • Uno A; NapaJen Pharma, Inc., Tokyo, Japan.
  • Sakurai K; Department of Chemistry and Biochemistry, University of Kitakyushu, Kitakyushu, Japan.
  • Mochizuki S; Department of Chemistry and Biochemistry, University of Kitakyushu, Kitakyushu, Japan.
  • Adachi Y; Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan.
  • Ohno N; Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan.
  • Zou H; Huashan Hospital, Fudan University, Shanghai, China.
  • Xu J; Huashan Hospital, Fudan University, Shanghai, China.
  • Li XK; Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Takahara S; Department of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Osaka, Japan.
Gene Ther ; 22(3): 217-26, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25567536

Full text: 1 Database: MEDLINE Main subject: Adjuvants, Immunologic / Heart Transplantation / Sizofiran / CD40 Antigens / Myeloid Cells / RNA, Small Interfering / Allografts Type of study: Prognostic_studies Limits: Animals Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2015 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Adjuvants, Immunologic / Heart Transplantation / Sizofiran / CD40 Antigens / Myeloid Cells / RNA, Small Interfering / Allografts Type of study: Prognostic_studies Limits: Animals Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2015 Type: Article Affiliation country: China